References
- WHO Global Tuberculosis Report 2022 https://iris.who.int/bitstream/handle/10665/363752/9789240061729-eng.pdf?sequence=1
- Allwood BW, Byrne A, Meghji J, Rachow A, van der Zalm MM, Schoch OD. Post-Tuberculosis Lung Disease: Clinical Review of an Under-Recognised Global Challenge. Respiration. 2021; 100(8):751-763. doi: 10.1159/000512531.
- Ma Y, Ye XP, Fu XY, Wu GH. Post-tuberculosis lung disease: a neglected disease. Zhonghua Jie He He Hu Xi Za Zhi. Chinese. 2022; 45(10):955-959. doi: 10.3760/cma.j.cn112147-20220208-00099.
- Allwood BW, van der Zalm MM, Amaral AFS, et al. Post-tuberculosis lung health: perspectives from the first International symposium. Int J Tuberc Lung Dis 2020;24:820–8. doi:10.5588/ijtld.20.0067
- Quaife M, Houben R, Allwood B, et al. Post-tuberculosis mortality and morbidity: valuing the hidden epidemic. Lancet Respir Med 2020; 8:332–3. doi:10.1016/S2213-2600(20)30039-4
- Vecino M, Pasipanodya JG, Slocum P, Bae S, Munguia G, Miller T, Fernandez M, Drewyer G, Weis SE. Evidence for chronic lung impairment in patients treated for pulmonary tuberculosis. J Infect Public Health. 2011; 4(5-6):244-52. doi: 10.1016/j.jiph.2011.08.005.
- Dodd PJ, Yuen CM, Jayasooriya SM, van der Zalm MM, Seddon JA. Quantifying the global number of tuberculosis survivors: a modelling study. Lancet Infect Dis. 2021; 21(7):984-992. doi: 10.1016/S1473-3099(20)30919-1.
- Singh S, Allwood BW, Chiyaka TL, Kleyhans L, Naidoo CC, Moodley S, Theron G, Segal LN. Immunologic and imaging signatures in post tuberculosis lung disease. Tuberculosis (Edinb). 2022; 136:102244. doi: 10.1016/j.tube.2022.102244.
- Gai X, Cao W, Rao Y, Zeng L, Xu W, Wu H, Li G, Sun Y. Risk factors and biomarkers for post-tuberculosis lung damage in a Chinese cohort of male smokers and non-smokers: protocol for a prospective observational study. BMJ Open. 2023 Oct 9;13(10):e065990. doi: 10.1136/bmjopen-2022-065990.
- Libu C, Otelea MR, Arghir IA, Rascu A, Antoniu SA, Arghir OC. Challenges in Diagnosing Occupational Chronic Obstructive Pulmonary Disease. Medicina (Kaunas). 2021; 57(9):911. doi: 10.3390/medicina57090911.
- Viragh E, Viragh K, Suciu H. Chronic bronchitis in oil industry workers exposed to hydrocarbons: role of cigarette smoking and gender differences. Tob Induc Dis. 2014; 12(Suppl 1):A32. doi: 10.1186/1617-9625-12-S1-A32.
- Webb GB. The effect of the inhalation of cigarette smoke on the lungs. A clinical study. Am Rev Tuberc. 1918 march;:25–7.
- van Zyl-Smit RN, Brunet L, Pai M, Yew WW. The convergence of the global smoking, COPD, tuberculosis, HIV, and respiratory infection epidemics. Infect Dis Clin North Am. 2010; 24(3):693-703. doi: 10.1016/j.idc.2010.04.012.
- Bates MN, Khalakdina A, Pai M, Chang L, Lessa F, Smith KR. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med. 2007; 167(4):335–42.
- Bansal A, Yanamaladoddi VR, Sarvepalli SS, Vemula SL, Aramadaka S, Mannam R, Sankara Narayanan R. Surviving Pulmonary Tuberculosis: Navigating the Long Term Respiratory Effects. Cureus. 2023 May 10;15(5):e38811. doi: 10.7759/cureus.38811.
- Sarkar M, Srinivasa, Madabhavi I, Kumar K. Tuberculosis associated chronic obstructive pulmonary disease. Clin Respir J. 2017; 11:285–295.
- Dhar, Singh S., Talwar D., et al. Bronchiectasis in India: results from the European multicentre bronchiectasis audit and research collaboration (EMBARC) and respiratory research network of India registry. Lancet Glob Heal 2019; 7: e1269–e1279.
- Fong I, Low TB, Yii A. Characterisation of the post-tuberculous phenotype of bronchiectasis: A real-world observational study. Chron Respir Dis. 2022 Jan-Dec;19:14799731221098714. doi: 10.1177/14799731221098714.
- Koo, HK., Min, J., Kim, H.W. et al. Cluster analysis categorizes five phenotypes of pulmonary tuberculosis. Sci Rep.2022; 12, 10084. https://doi.org/10.1038/s41598-022-13526-1.